By 72 hours after surgery (POD 3), the Welpass group had an average dose of 3.8 ± 13.5 mg, while no ketorolac was administered in the On-Q PainBuster group; this difference also did not reach statistical significance (P = 0.185).
← all excerpts
A prospective randomized trial comparing the efficacy of temperature-responsive gel with local anesthetics <i>versus</i> local anesthetic infusion pump device for postoperative pain control after bariatric surgery.
1
0.1850
0.1850